Cipla Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Cipla Ltd. from all sources in a single place.

Load latest

Cipla Ltd.

26 Oct 2021

1479.40

-0.38%

Company Update

CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

BSE India

Please find enclosed intimation dated 26th October 2021

pdf

Cipla Ltd.

14 Oct 2021

1479.40

-0.38%

Company Update

CIPLA LTD. - 500087 - Shareholding for the Period Ended September 30, 2021

BSE India

Cipla Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here

Cipla Ltd.

14 Oct 2021

1479.40

-0.38%

Company Update

Cipla Ltd - 500087 - Statement Of Investor Complaints For The Quarter Ended September 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- Rajendra ChopraDesignation :- Company Secretary and Compliance Officer

Cipla Ltd.

06 Oct 2021

1479.40

-0.38%

Cipla Q2 PAT seen up 20.3% YoY to Rs 793.4 cr: Prabhudas Lilladher

Moneycontrol

Net Sales are expected to increase by 4 percent Y-o-Y (down 5.5 percent Q-o-Q) to Rs 5,169.7 crore, according to Prabhudas Lilladher.

Cipla Ltd. has an average target of 1702.12 from 8 brokers.

Cipla Ltd.

05 Oct 2021

1479.40

-0.38%

Corp. Note

CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate …

BSE India

In compliance with the requirements of Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company vide intimation dated 22nd September, 2021 informed about the request received for issuance of duplicate share certificate in lieu of the loss of original share certificate by Mrs. Hasumati Wadia (legal heir) w/o Late Mr. Rasiklal J Wadia. In furtherance to the last intimation, it is hereby notified that vide approval of the Stakeholders Relationship Committee on 4th October, 2021, the Company has cancelled the original share certificates nos. 500537 and 659892 and has issued the duplicate share certificates.

pdf

Cipla Ltd.

04 Oct 2021

1479.40

-0.38%

Company Update

Cipla Ltd - 500087 - Earnings Conference Call

BSE India

Please find enclosed schedule of Earnings Conference Call to be held on 26th October 2021.

pdf

Cipla Ltd.

04 Oct 2021

1479.40

-0.38%

Cipla to sell Eli Lilly's Trulicity, Humalog diabetes treatments in India

Business Today

Lilly will transfer its rights in India to sell, promote and distribute its Trulicity and Humalog products, while continuing to maintain its existing operating model for the remaining portfolio of its products

Cipla Ltd. is trading below all available SMAs

Eli Lilly to transfer rights of two diabetes products to Cipla

Moneycontrol | 04 Oct 2021 2 more

Cipla Ltd.

04 Oct 2021

1479.40

-0.38%

Company Update

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Eli Lilly and Cipla enter into a strategic partnership in India to enhance access to Lilly's key diabetes products

pdf

Cipla Ltd.

01 Oct 2021

1479.40

-0.38%

Cipla eyes acquisitions in India, US after Covid-led windfall

Business Standard

With a funding frenzy currently underway in India, Cipla may struggle to find attractive targets

Cipla Ltd. is trading below all available SMAs

Cipla's shares echo investors' bet on sustained core growth

livemint | 30 Sep 2021

Cipla Ltd.

30 Sep 2021

1479.40

-0.38%

Board Meeting

Cipla Ltd - 500087 - Board Meeting Intimation for Notice Of The Board Meeting To Consider …

BSE India

CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2021 ,inter alia, to consider and approve This is to inform you that meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 26th October, 2021 inter-alia to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended 30th September, 2021. In terms of the Company's Code of Conduct for Prevention of Insider Trading, the 'Trading Window' for dealing in the securities of the Company will be closed from 1st October, 2021 till 28th October, 2021, for the purpose of financial results.

pdf

Is Cipla Ltd. worth buying?

616 Votes:

Buy 75.81%

Sell 14.12%

Hold 10.06%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf